Ke Li
Corporate Officer/Principal en Shenyang Sunshine Pharmaceuticals Co., Ltd. .
Perfil
Ke Li is a professional who has worked as a Vice President at Shenyang Sunshine Pharmaceuticals Co., Ltd.
since 1993.
Prior to this, Mr. Li worked as a Vice President at 3SBio, Inc. Mr. Li received an undergraduate degree from Jilin University in 1988 and another undergraduate degree from Liaoning University in 2001.
Cargos activos de Ke Li
| Empresas | Cargo | Inicio |
|---|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Corporate Officer/Principal | 01/03/1993 |
Antiguos cargos conocidos de Ke Li.
| Empresas | Cargo | Fin |
|---|---|---|
| 3SBIO INC. | Corporate Officer/Principal | - |
Formación de Ke Li.
| Jilin University | Undergraduate Degree |
| Liaoning University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| 3SBIO INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
